User profiles for K Kondo

Karli Kondo

American Cancer Society
Verified email at cancer.org
Cited by 3377

The CDF detector: an overview

…, S Kim, L Kirsch, S Kobayashi, K Kondo… - Nuclear Instruments and …, 1988 - Elsevier
The Collider Detector at Fermilab (CDF) is a 5000 t magnetic detector built to study 2 TeV p
p collisions at the Fermilab Tevatron. Event analysis is based on charged particle tracking, …

Racial and ethnic disparities in COVID-19–related infections, hospitalizations, and deaths: a systematic review

K Mackey, CK Ayers, KK Kondo, S Saha… - Annals of internal …, 2021 - acpjournals.org
Background: Data suggest that the effects of coronavirus disease 2019 (COVID-19) differ
among US racial/ethnic groups. Purpose: To evaluate racial/ethnic disparities in severe acute …

[HTML][HTML] The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the …

…, L Kingsbury, H Kondo, M Krasnik, K Kubota… - Journal of Thoracic …, 2016 - Elsevier
This article proposes codes for the primary tumor categories of adenocarcinoma in situ (AIS)
and minimally invasive adenocarcinoma (MIA) and a uniform way to measure tumor size in …

[HTML][HTML] The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung …

…, L Kingsbury, H Kondo, M Krasnik, K Kubota… - Journal of Thoracic …, 2016 - Elsevier
The IASLC Staging and Prognostic Factors Committee has collected a new database of
94,708 cases donated from 35 sources in 16 countries around the globe. This has now been …

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma …

…, V Poulart, D Cullen, M Lei, H Xiao, K Kondo… - The Lancet, 2021 - thelancet.com
Background First-line chemotherapy for advanced or metastatic human epidermal growth
factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction adenocarcinoma …

[HTML][HTML] A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

…, J Takamino, M Ueno, H Sakata, K Kondo… - International journal of …, 2020 - Elsevier
Novel coronavirus (SARS-Coronavirus-2:SARS-CoV-2) which emerged in Wuhan, China,
has spread to multiple countries rapidly. We report the first case of meningitis associated with …

Cell interactions in the induction of tolerance: the role of thymic lymphocytes

RK Gershon, K Kondo - Immunology, 1970 - ncbi.nlm.nih.gov
… RK Gershon and K. Kondo cell inoculation. By comparing these animals with non-pretreated
controls (Group 1) it can be seen that their antibody titre was depressed on day 5 (P< 0.05) …

Infectious immunological tolerance

RK Gershon, K Kondo - Immunology, 1971 - ncbi.nlm.nih.gov
… RK Gershon and K. Kondo To gain further insight into how the co-operation of these two
cell types had been abrogated, we have transferred the spleen cells of pretreated mice into …

[HTML][HTML] Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer

…, J Zhang, L Zhu, M Lei, P Singh, K Kondo… - … England Journal of …, 2021 - Mass Medical Soc
Background No adjuvant treatment has been established for patients who remain at high
risk for recurrence after neoadjuvant chemoradiotherapy and surgery for esophageal or …

[HTML][HTML] Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma

…, T Makino, I Xynos, X Liu, M Lei, K Kondo… - … England Journal of …, 2022 - Mass Medical Soc
Background First-line chemotherapy for advanced esophageal squamous-cell carcinoma
results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival …